Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Austin Lewis IV currently holds 3,671,125 shares of Medite Cancer Diagnostics, Inc. (MDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Austin Lewis IV has been a net seller of MDIT stock. They have purchased $4.2M and sold $5.3M worth of shares.
William Austin Lewis IV's most recent insider trade was on Mar 5, 2026, when they sold 37,072 shares at $2.40 per share.
William Austin Lewis IV serves as Executive at Medite Cancer Diagnostics, Inc. (MDIT). They have executed 127 insider transactions totaling $9.5M over their tenure at the company.
William Austin Lewis IV holds the position of Executive at Medite Cancer Diagnostics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
William Austin Lewis IV has shown a selling trading pattern, with $4.2M in total purchases and $5.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by William Austin Lewis IV was on Oct 21, 2019, when they sold $7.4M worth of MAMS shares. This transaction involved 606,441 shares at $12.12 per share.
William Austin Lewis IV currently owns 3,671,125 shares of Medite Cancer Diagnostics, Inc. (MDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Austin Lewis IV's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Austin Lewis IV has 127 Form 4 filings on record as an insider at Medite Cancer Diagnostics, Inc..
Set alerts for William Austin Lewis IV and 40,000+ other insiders.